Emergence Dental receives $200,000 research support from Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center to further dental bone grafting system in partnership with nanoMAG
Pittsburgh, PA – November 17, 2021 – Emergence Dental and development partner nanoMAG have received $200,000 in renewed research support from the Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center, which is funded by the National Institute of Dental and Craniofacial Research (Grant U24DE026915). This competitive renewal marks the fourth round of research funding, totaling $650,000, from the Resource Center to the Emergence Dental-nanoMAG team for development of the AmpliMag Bone Grafting System.
The AmpliMag Bone Grafting System is made up of a mesh and screws that provide stability for healing dental bone grafts that many patients receive prior to the placement of dental implants. Unlike titanium meshes and screws that are used in these procedures today, the AmpliMag Bone Grafting System relies on a patented magnesium alloy, produced by nanoMAG, that provides a friendlier environment for soft tissue healing while eventually resorbing to be replaced by bone.
”The current Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center funding will help us finalize plans for the remaining pre-clinical studies of Emergence Dental,” said Andrew Brown, PhD, Founder & CEO of Emergence Dental. “The Resource Center has also provided dental-specific regulatory, market, clinical, and scientific expertise which has been as important as the funding itself for accelerating our development activities,” Dr. Brown continued.
Though dental implants are a popular and predictable solution for many patients with missing teeth, bone grafting performed in advance of dental implant placement is an imperfect solution. “Even in the hands of expert oral surgeons and periodontists, we often struggle to achieve the perfect clinical outcomes that we strive for with the grafting materials we have today,” said Kelly Williams, DMD, founding member of Emergence Dental’s Clinical Advisory Board. “The AmpliMag Bone Grafting System combines the strength of metals with soft tissue friendliness and resorbability to provide more predictable bone grafting outcomes for patients and their dental specialists,” continued Dr. Williams.
Emergence Dental recently completed the AlphaLab Health accelerator program and is continuing to work out of space in the Suburban General Hospital complex. The four rounds of funding from Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center expand the company’s ability to develop their AmpliMag Bone Grafting System, achieve FDA clearance and market their product.
CONTACT: Andrew Brown, PhD